Mieke De Buck

714 total citations
12 papers, 543 citations indexed

About

Mieke De Buck is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Mieke De Buck has authored 12 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Immunology and Allergy and 4 papers in Oncology. Recurrent topics in Mieke De Buck's work include Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Cell Adhesion Molecules Research (7 papers) and S100 Proteins and Annexins (3 papers). Mieke De Buck is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Cell Adhesion Molecules Research (7 papers) and S100 Proteins and Annexins (3 papers). Mieke De Buck collaborates with scholars based in Belgium, Brazil and United States. Mieke De Buck's co-authors include Sofie Struyf, Jo Van Damme, Mieke Gouwy, Ghislain Opdenakker, Paul Proost, Jacques Van Snick, Ji Wang, Ji Ming Wang, Nele Berghmans and Noëmie Pörtner and has published in prestigious journals such as Blood, Frontiers in Immunology and European Journal of Immunology.

In The Last Decade

Mieke De Buck

12 papers receiving 536 citations

Peers

Mieke De Buck
Comparison fields: 5 of 89
  • Molecular Biology 276
  • Immunology 152
  • Surgery 122
  • Oncology 94
  • Epidemiology 84
Peter Astrup Christensen Denmark
Fionnuala B. Hickey Ireland
Christina Stoeckle Switzerland
Laura Horváth Hungary
R Chen China
Masamichi Isobe Japan
Qiusha Guo United States
Masato Ohta Japan
Chaokui Wang China
Gavin Pickett United States
Peter Astrup Christensen Denmark View profile →
Citations per field, relative to Mieke De Buck
Mieke De Buck · 1×
Citations per year, relative to Mieke De Buck
Mieke De Buck · 1×

Countries citing papers authored by Mieke De Buck

Since Specialization
Citations

This map shows the geographic impact of Mieke De Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieke De Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieke De Buck more than expected).

Fields of papers citing papers by Mieke De Buck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mieke De Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieke De Buck. The network helps show where Mieke De Buck may publish in the future.

Co-authorship network of co-authors of Mieke De Buck

This figure shows the co-authorship network connecting the top 25 collaborators of Mieke De Buck. A scholar is included among the top collaborators of Mieke De Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mieke De Buck. Mieke De Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
# Work Indexed citations
1 4
2 43
3 6
4 28
5 16
6 15
7 25
8 177
9 112
10 43
11 57
12 17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026